xtock / Shutterstock.com
The Court of Justice of the European Union (CJEU) has ended the uncertainty over the term of supplementary protection certificates (SPCs) by ruling that they begin once a party is notified of a marketing authorisation for a drug.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
SPCs; CJEU; Advocate General; Seattle Genetics; Austrian Patent Office; supplementary protection certificates